Abstract: Sodium 2-(5-bromo-4-(4-cyclopropyl-naphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate is described. In addition, pharmaceutical compositions and uses such compositions for the treatment of a variety of diseases and conditions.
Type:
Application
Filed:
March 29, 2011
Publication date:
March 7, 2013
Applicant:
Ardea Biociences, Inc.
Inventors:
Jeffrey Miner, Jean-Luc Girardet, Barry D. Quart